Biotinylated HPMA Centered Polymeric Nanoparticles for Bortezomib Delivery.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2020.119173
Abstract: Bortezomib (BTZ) is a proteasome inhibitor as approved by US FDA for the treatment of multiple myeloma. It exhibits significant anti-cancer properties including against solid tumors; but lacks aqueous solubility, chemical stability which hinders its… read more here.
Keywords: polymeric nanoparticles; biotinylated hpma; delivery; hpma ... See more keywords